Abstract
Adalimumab, an entirely human monoclonal antibody, specifically blocks the cell-surface receptor relationship of tumor necrosis factor-alpha (TNF-alph......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
